Palummo M, Cingolani A, Dall L, Volonté M G
Cátedra de Ensayo y Valoración de Medicamentos, Facultad de Ciencias Exactas, UNLP, La Plata, Argentina.
Boll Chim Farm. 2000 May-Jun;139(3):124-8.
The aim of the present study was to comparatively evaluate the stability of capsules containing 20 mg of Omeprazole, in enteric coated pellets, from seven pharmaceutical laboratories on Argentine market. The stability test was performed under the conditions indicated by the ICH: 40 degrees C, 75% HR, with and without light, during a six month period. The remaining content of Omeprazole, total percentage of impurities and percentage of released active principle in vitro, were determined by HPLC. The organoleptic characteristics of the pellets were visually examined. The results obtained at six months indicate that, from the seven products studied, four were found to have a content of Omeprazole higher than 90% of the labeled amount, in both lighting conditions tested, and also comply with the USP23 specifications with respect to the release in vitro. We conclude that the progressive darkening of the pellets indicates, qualitatively, the level of degradation of the product and that the stability of Omeprazole depends on the correct formulation and the primary container.
本研究的目的是比较评估阿根廷市场上七个制药实验室生产的含20毫克奥美拉唑肠溶包衣微丸胶囊的稳定性。稳定性试验在国际协调会议(ICH)规定的条件下进行:40摄氏度,相对湿度75%,有光照和无光照条件下,为期六个月。采用高效液相色谱法(HPLC)测定奥美拉唑的剩余含量、杂质总百分比以及体外活性成分释放百分比。目视检查微丸的感官特性。六个月时获得的结果表明,在所研究的七种产品中,在两种光照条件下,有四种产品的奥美拉唑含量高于标示量的90%,并且在体外释放方面也符合美国药典第23版的规格。我们得出结论,微丸逐渐变黑在质量上表明了产品的降解程度,并且奥美拉唑的稳定性取决于正确的配方和初级包装。